Amy Harman, MS

Amy Harman is Senior Vice President, Clinical Sciences, at Kriya Therapeutics. Prior to joining Kriya, Amy spent more than seven years at Regeneron Pharmaceuticals in progressively senior roles spanning clinical operations and global development strategy. Prior to Regeneron, Amy held scientific and operational leadership roles at CSL Behring, Shire, and Merck & Co., spanning early and late-stage clinical development. At CSL Behring, she provided scientific leadership across early pipeline programs including those in acquired bleeding disorders and sickle cell disease, and established and led the company’s Early Clinical Scientist group.

Amy received her MS in clinical research from Drexel University and her BS in biology from Moravian College.